eMolecules Acquires Synple Chem AG
September 24, 2024
eMolecules, a San Diego-based provider of a chemical compound search-and-fulfillment platform and a portfolio company of Avista Healthcare Partners, has acquired Synple Chem AG, an automated chemical synthesis systems and services provider headquartered near Zurich, Switzerland. The acquisition adds Synple's automation technology and a virtual compound library of more than 7 trillion tractable compounds to eMolecules' existing offering, expanding its capabilities as a one-stop shop for compound procurement, management and automation for drug discovery customers.
- Buyers
- eMolecules, Inc.
- Targets
- Synple Chem AG
- Platforms
- eMolecules, Inc.
- Industry
- Biotechnology
- Location
- Zurich, Switzerland
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
eMolecules Acquires Specs Compound Handling B.V.
May 25, 2023
Healthcare Services
eMolecules, a San Diego–based chemical compound search-and-fulfillment platform, has acquired Specs Compound Handling B.V., a Netherlands-headquartered provider of compound reformatting, repository and management services. The acquisition expands eMolecules' global compound reformatting and inventory management footprint—adding European and US facilities—and is supported by eMolecules' existing investors, including Avista Capital Partners.
-
X-Chem Acquires IntelliSyn and AviSyn to Expand Drug Discovery Services
January 26, 2021
Biotechnology
X-Chem, a portfolio company of GHO Capital, has acquired Montreal-based IntelliSyn and its US-based sister company AviSyn to extend its drug discovery offering into medicinal chemistry, custom synthesis and scale-up process chemistry. The deal integrates downstream hit validation and lead optimisation capabilities into X-Chem’s DNA-Encoded Library (DEL) platform, enabling a streamlined screen-to-lead service for pharma and biotech clients; financial terms were not disclosed.
-
Avista Capital Partners Invests in eMolecules
March 25, 2021
Healthcare Services
Avista Capital Partners has signed a definitive agreement to invest in eMolecules, a San Diego–based e-procurement and marketplace platform for high-value chemicals and bioreagents used in drug discovery. Financial terms were not disclosed; Avista said the investment will support eMolecules' growth and expansion into additional biopharma and academic customers.
-
3E Acquires ChemChain
January 11, 2024
Cloud & SaaS
3E has acquired ChemChain, a Luxembourg-headquartered provider of blockchain-based digital product passport technology, to expand its Supply Chain & Sustainability offering and enhance the 3E Exchange platform. The acquisition brings ChemChain's proprietary IP and technology into 3E's compliance and digital product passport capabilities to accelerate supply chain transparency and sustainability solutions.
-
Chemstream Acquires Synthex Organics
October 26, 2025
Manufacturing
Chemstream has merged with and acquired Synthex Organics, combining Chemstream's chemical distribution, logistics and fluid systems capabilities with Synthex's specialty chemical manufacturing and R&D. The combined company will operate under the Chemstream name with integrated operations and expanded R&D and manufacturing hubs across multiple U.S. states to better serve oil & gas, water treatment, pulp & paper and mining customers.
-
Meridian Adhesives Group Acquires E-Chem
July 3, 2020
Building Products
Meridian Adhesives Group has acquired E-Chem, a New Mexico-based designer and manufacturer of epoxy polymer products for concrete. E-Chem will join Meridian’s Infrastructure Division to expand Meridian’s presence in the infrastructure and concrete rehabilitation markets and leverage Meridian’s distributor network and resources to accelerate product development and market penetration.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.